Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-Drug Conjugates: A Review
Year: 2021
Type: review
Source: JAMA Oncology
Institutions: University of Milan, European Institute of Oncology, Memorial Sloan Kettering Cancer Center, Weill Cornell Medicine, Dana-Farber Cancer Institute, Vall d'Hebron Institute of Oncology, IDCQ Hospitales y Sanidad, S.L.U., Tennessee Oncology, Asan Medical Center, University of Ulsan, Kyoto University, Kyoto University Hospital, Institut Gustave Roussy, Fondation Gustave Roussy
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3205051299
